1 / 21

CHMP Guideline on conduct of Pharmacovigilance for medicines used by the paediatric population, Konzepte f r die Langzei

anahid
Télécharger la présentation

CHMP Guideline on conduct of Pharmacovigilance for medicines used by the paediatric population, Konzepte f r die Langzei

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. CHMP Guideline on conduct of Pharmacovigilance for medicines used by the paediatric population, Konzepte fr die Langzeitverfolgung von Patienten

    2. 4

    3. Impicciatore P et al Br J Clin Pharmacol, 52, 77-83

    4. 3

    5. Nebenwirkungen bei Kindern sind ein signifikantes, aber wenig erforschtes Problem Nebenwirkungen kommen bei hospitalisierten Kindern hufiger vor als im ambulanten Bereich Jngere Kinder sind offenbar besonders prdisponiert fr Nebenwirkungen Kinder, die Arzneimittel Off-label erhalten haben, haben scheinbar ein hheres Risiko fr Nebenwirkungen Um robuste Aussagen machen zu knnen, sind jedoch weitere Daten erforderlich Pdiatrische Pharmakovigilanz

    12. 27

    14. 27

    21. Arzneimittelsicherheit in der Pdiatrie: Die Spitze des Eisberges?

More Related